Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 49, 2019 - Issue 3
342
Views
3
CrossRef citations to date
0
Altmetric
Articles

Synthesis and characterization of potential impurities of Vigabatrin-An anti epileptic drug

, , , , &
Pages 359-366 | Received 18 Aug 2018, Accepted 15 Nov 2018, Published online: 21 Jan 2019
 

Abstract

The present work describes the synthesis and characterization of four potential impurities of Vigabatrin (Citation1) namely 2-(2-aminobut-3-enyl)malonic acid (Citation2) (Vigabatrin USP impurity-E), 2-(2-oxo-5-vinylpyrrolidin-1-yl)acetic acid (Citation3) (USP Tablets impurity), 4-aminohexanoic acid (Citation4) and 2,2′-oxo-5,5′-bispyrrolidinyl ether (Citation5). Compound 4 is a possible process related impurity of 1 where as compound 5 is a process related impurity of 5-ethoxy-2-pyrrolinone (16). All these impurities have a significant impact on the quality of the drug product. This work is extremely useful for generic pharmaceutical industry.

Graphical Abstract

Acknowledgement

The authors gratefully acknowledge Aurobindo Pharma Limited for supporting the work. The authors are also thankful to the Chemical Research Department and Analytical Research Department for the support and co-operation.

Supporting Information

Full experiment detail, 1H NMR spectra, 13C NMR spectra and HRMS. This material can be found via the “Supplementary Content” section of this article’s webpage.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.